Background: Antiretrovirals (ARVs) could lead to clinically significant nephrotoxicity and as such will require dose adjustments in the presence of renal insufficiency. Objective: To explore renal function estimating equations as alternatives for glomerular filtration rate (GFR) measurement in a stable cohort of HIV-infected patients. Method: In estimating renal insufficiency in Ghanaian HIV-infected patients, GFR for 276 HAART-naïve patients and 166 patients on HAART was estimated with the Cockcroft-Gault, 4v-MDRD and CKD-EPI estimating equations. Results: Females outnumbered males by 3 to 1 in the HAART-naïve group and 4 to 1 in subjects on HAART. The prevalence of renal insufficiency calculated with the Cockcroft-Gault, 4v-MDRD and CKD-EPI equations was 8.7%, 9.1% and 8.7% in HAART-naïve patients; 14.5%, 12.6% and 12.6% in patients on HAART; 7.7%, 11.5% and 11.5% in HAARTnaïve males; 10.8%, 8.1% and 8.1% in males on HAART; 9.1%, 8.0% and 7.5% in HAART-naïve females and 15.5%, 14.0% and 14.0% in females on HAART. The CKD-EPI equation yielded lower bias when compared to the Cockcroft-Gault and 4v-MDRD equations. Conclusion: Renal insufficiency is not uncommon among HIV infected Ghanaian patients. A significant proportion (10 to 11%) will require ARV dose adjustment at the time of initiating therapy or sometime during on-going therapy.
Introduction
Chronic kidney disease (CKD) is essentially compromised kidney function that persists for more than three (3) months 1 . Chronic kidney disease is becoming a public health problem with recently published reports emphasizing it as being underdiagnosed and under-treated 2, 3 . Recognition of this chronic condition is therefore crucial to facilitate the employment of measures that can slow progression to end-stage renal disease (ESRD).
Abnormal renal function has been identified in about 30% of human immunodeficiency virus (HIV) infected patients 4 and a more recent analysis of a large urban United States (US) HIV clinic showed that approximately 15.5% of the patients had chronic or end-stage renal disease 5 . Individuals of African descent have been impacted most by renal disease as a complication of HIV infection with HIV-associated nephropathy (HIVAN) being the most commonly detected abnormality 6, 7 . Human immunodeficiency virus associated nephropathy has been documented in sub-Saharan Africa 8, 9 but little is known about its prevalence or impact. Antiretroviral (ARV) drug combination regimen has been proven to prolong life and reduce HIV-related morbidity and mortality 10 and discontinuation of ARV has been shown to increase mortality not just from HIV but also from other causes. Against the background that some antiretroviral therapies have been identified to have clinically significant nephrotoxicity, anticipation and management of the complications of long-term antiretroviral therapy (drug induced kidney damage) and long-standing HIV infection (HIVAN) are becoming increasingly important.
Current guidelines for the management of HIV-infected patients include initial assessment to rule out kidney disease and to identify patients at risk for developing kidney disease 11 . Glomerular filtration rate (GFR) compared to serum creatinine or 24-hour urine creatinine measurement is considered the best overall index of kidney function in health and disease because of the attendant problems associated with creatinine measurement and 24-hour urine creatinine clearance estimation 12, 13 . Kidney function can be reliably estimated by calculating creatinine clearance (CrCl) or GFR through use of the Cockcroft-Gault or Modification of Diet in Renal Disease (MDRD) equations respectively 14, 15 . A GFR <60 mL/min/1.73m 2 meets the criteria for renal insufficiency and this cut-off is supported by epidemiological data linking lower GFR to an increased frequency of hospitalization, cardiovascular events or death. Neither of the equations has been specifically validated in the HIV-infected population but they remain the most highly validated formulas available and both equations are more sensitive than measurement of serum creatinine alone 16 . With the formulation of the chronic kidney disease epidemiology collaboration (CKD-EPI) equation which has been found to be more accurate than the MDRD equation, this paper seeks to find the proportion of Ghanaian HIV-infected patients (HAART naïve and on HAART) with renal insufficiency by using the three renal function equations to assess which of the equations best defines renal insufficiency in the study population and also to determine the proportion of the study population who would require ART dose adjustments. 
Methods

Study setting
Study population
Four hundred and forty-two people living with HIV/AIDS (PLWHA) visiting the ART clinic at the Regional Hospital, Bolgatanga were recruited for this study. This comprised of two hundred and seventysix highly active antiretroviral therapy (HAART)-naïve patients and one hundred and sixty-six patients on HAART.
Inclusion criteria
Patients with age ranging between 20 to 60 years, confirmed to be positive for HIV 1, 2 or both and have undergone adherence counselling at the ART clinic were included in the study.
Exclusion criteria
Patients who were hypertensive, diabetic, pregnant and had recorded history of renal disease were excluded from the study. Written informed consent was obtained from all the patients included in the study and ethical clearance was obtained from the Clinical and Research Development Board of the hospital.
Sample collection and preparation 5 ml of venous blood was taken from each patient. 3 ml was dispensed into vacutainer plain tube and allowed to clot. The clotted sample was then centrifuged at 1500 rpm for 10 minutes at room temperature to obtain serum which were kept frozen at -20 o C until analyzed. The remaining 2 ml of the venous blood sample was dispensed into vacutainer ethylene diamine tetraacetic acid (EDTA) tubes and was used for CD4 and CD3 estimation.
Study procedures Weight
Weight to the nearest 0.1kg in light clothing was determined at the time of recruitment with a bathroom scale (Zhongshan Camry Electronics Co. Ltd. Guangdong, China).
CD4 and CD3 Lymphocytes
Absolute cell counts of CD4 and CD3 Tlymphocytes in non-haemolyzed whole blood were assayed using the BD FACSCOUNT system (Becton Dickenson and Company, California, USA) which uses fluorescent light to provide the information necessary for the instrument to count cells.
Biochemical assays Urea
The method for this assay is based on a modification of the Urease/Glutamate dehydrogenase (GLDH) method by 17 where urea is hydrolyzed to ammonia (NH 3 ) and carbon dioxide (CO 2 ) in the presence of water and urease. Liberated ammonia reacts with á-ketoglutarate in the presence of NADH and GLDH to form L-Glutamate and NAD + . As the reaction proceeds, the absorbance at 340 nm decreases and the initial rate of this change is proportional to the amount of urea in the sample.
Creatinine
This assay is based on the Jaffe (modified kinetic) method described by 18 . Creatinine reacts with picric acid in alkaline conditions to form a colour complex which absorbs at 510 nm. The rate of formation of colour is proportional to the creatinine in the sample.
Albumin
This assay is based on the method of [19] where at a controlled pH, bromocresol green (BCG) forms a coloured complex with albumin. The intensity of the colour at 630 nm is directly proportional to the albumin content.
All biochemical assays were determined using ATAC 8000 Random Chemistry Analyzer according to the reagent manufacturer's instruction -JAS TM diagnostics, Inc. (JAS Diagnostics, Inc. Miami Florida, USA). HAART usage is defined as receipt of two nucleoside reverse transcriptase inhibitors (NRTI) and one non-nucleoside reverse transcriptase inhibitor (NNRTI) or one protease inhibitor (PI).
Measurement of renal function
The Infectious Diseases Society of America (IDSA) renal guidelines state that for CKD staging purposes, the simplified MDRD equation is preferred but for dosage modification, the Cockcroft-Gault would be appropriate as studies of medications in renal failure have traditionally used the Cockcroft-Gault equation 11 . Currently, the only validated renal function equation in Ghana is among CKD patients where Cockcroft-Gault and four-variable Modification of Diet in Renal Disease (4v-MDRD) equations were recommended out of the six equations validated 20 . This study assessed renal function in HIV patients using three renal function equations, namely the Cockcroft-Gault equation for estimating CrCl, 4v-MDRD and the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI). None of these renal function estimating equations have been validated against accepted gold standards among Ghanaian HIV infected patients.
Gold standards
Clearance of inulin, iothalamate and other radioisotopes as measurements for GFR are not readily available and too expensive to be used for screening. Creatinine clearance therefore remains the most widely used, widely available and sufficiently accurate method for measuring GFR but the required 24-hour urine collection is too cumbersome and potentially beset by pitfalls. Unfortunately, none of the estimating equations used in this study were compared to a gold standard.
Estimating equations and Staging of kidney function Estimated GFR's (eGFR) were used to stratify the study population into five stages based on the staging system of the Kidney Disease Outcomes Quality Initiative (K/DOQI) for renal disease classification 
Renal function estimating equations
Units of measurement: Age (years); creatinine (mg/dL); weight (kg); GFR (mL/min/ (table 1) . Combivir is a combined drug of Zidovudine (AZT) and Lamivudine (3TC). Results are presented as means ± SEM and Proportions of drug use. *P < 0.05, **P < 0.001, ***P < 0.0001 indicates the level of significance when HAART-naïve were compared to those on HAART (unpaired t-test); † P< 0.05, † † P <0.001, † † † P < 0.0001 indicates the level of significance when male HAART-naïve were compared to males on HAART; § P < 0.05, § § P < 0.001, § § § P < 0.0001 indicates the level of significance when female HAART-naïve were compared to females on HAART; ‡ P < 0.05, ‡ ‡ P < 0.001, ‡ ‡ ‡ P< 0.0001 indicates the level of significance when male HAART-naïve were compared to the female HAART-naïve; # P < 0.05, ## P <0.001, ### P < 0.0001 indicates the level of significance when the male on HAART were compared to the female on HAART. CBV: Combivir, EFV: Efavirenz, NVP: Nevirapine, d4T: Stavudine, 3TC: Lamivudine, HAART: Highly Active Antiretoviral Therapy. Estimated GFR's and prevalence of renal insufficiency Table 2 shows the mean estimated GFR's of the study population as determined with the three estimating equations presented as means ± SEM. In Table 4 shows summarized beta (â) and "r squared (r 2 )" values of multiple linear regression analysis of some study parameters with the exception of CD4 for which variability changes are known to have varied effects on serum creatinine concentration and estimated GFR with the three renal function equations. Serum creatinine showed a consistent reciprocal relationship to estimated GFR with r 2 values observed in CKD-EPI equation > 4v-MDRD > Cockcroft-Gault equations respectively in all the study populations. CD4 was the next predictor variable which showed a consistent positive relationship with estimated GFR. Generally, r 2 values in the CockcroftGault equation > 4v-MDRD > CKD-EPI equations respectively with exceptions in HIV patients on HAART (r 2 in 4v-MDRD = CKD-EPI); HAARTnaïve males (r 2 in CKD-EPI > 4v-MDRD) and females on HAART (r 2 in Cockcroft-Gault and 4v-MDRD = 0%; CKD-EPI = 1%). Weight was the next predictor in succession and it also showed a positive relationship to GFR with the exception of observed negative associations in the 4v-MDRD and CKD-EPI equations for females on HAART. Strong r 2 values were observed in the CockcroftGault equation compared to the 4v-MDRD and CKD-EPI equations with an exception in females on HAART where the r 2 in Cockcroft-Gault = 0% and 1% in 4v-MDRD and CKD-EPI equations respectively. Age was the next in succession showing a generally negative or reciprocal relationship to estimated GFR with exceptions of positive associations in males on HAART and estimated GFR by Cockcroft-Gault in HAART-naïve males. There was no consistency in the r 2 values calculated for the three equations in all the study populations. Serum albumin concentration was the last predictor in succession and it showed reciprocal relationship in the HAART naïve study population (naïve males and females) and positive linear relationship in the subject population on HAART (males and females on HAART). Again, there was no consistency in the calculated r 2 values for all the study populations. Therefore in grading the predictor variables with regard to strength of association and percentage variability with estimated GFR in the study population, the outcome is creatinine > CD4 > weight > age > albumin. . The calculated incidence of renal insufficiency (GFR <60mL/min/ 1.73m 2 ; stages 3, 4 & 5) in male and female patients (HAART-naïve + on HAART) was 9.8% and 11.1% respectively giving an overall average incidence of 10.5% using the 4v-MDRD equation 21 reported a renal insufficiency (CrCl <60mL/min and <50mL/ min) incidence of 11.5% and 4.8% respectively in a cross-sectional study in an antiretroviral (ARV) naïve Kenyan population. This significant finding suggests that renal insufficiency is a growing health concern in our study population and it is certainly underdiagnosed and under-treated considering the fact that apart from results of full serum chemistries, none of the study participants had a documented creatinine clearance on which antiretroviral (ART) dosing was based. The provision of absolute creatinine values rather than calculated creatinine clearance values by most laboratories for patients is not in keeping with recommended guidelines of the IDSA which recommends that therapy should be dependent on level of creatinine clearance. Renal insufficiency in this study as estimated by the Cockcroft-Gault equation in male and female (on HAART + HAART-naïve) patients was 8.4% and 13.2% respectively giving an overall average of 10.8%. A significant proportion of our study population may therefore have required dosage adjustment at the time of initiation of therapy or sometime during on-going therapy.
Study parameters as predictor variables
Dose adjustment
The Infectious Diseases Society of America ART dosing recommendations suggests that appropriate reduction of dosing for ART's that are primarily eliminated by the kidneys is warranted. Dose adjustments for NNRTI's in patients with renal insufficiency is not required because NNRTI's in general are much more tightly bound to plasma proteins and are primarily metabolized by the liver 11 . They also have high molecular weights and are excreted into the urine in low amounts. Nevirapine, however, does not fully share the drug properties of the other NNRTI's because of its relatively low molecular weight and protein-binding fraction 11 . It has therefore been suggested that dialysis may remove substantial amounts of the drug and that it should be administered after dialysis. Nucleoside reverse transcriptase inhibitors on the other hand are primarily excreted by the kidneys, therefore reduced dosage is required in patients with impaired renal function, especially for a drug like stavudine, which requires further reduction because its pharmacokinetics is influenced by weight 11 . Furthermore, because NRTI's are neither tightly bound to protein nor have a high molecular weight, they may be easily removed by dialysis. The drug regimen for the study population includes the standard combination therapy of 2 NRTI's and 1 NNRTI. The NRTI's include stavudine (d4T), lamivudine (3TC) and combivir (combined drug of Zidovudine (AZT) + 3TC) and the NNRTI's includes efavirenz (EFV) and Nevirapine (NVP). The study population on d4T and 3TC who present with renal insufficiency will require dose adjustments as per the IDSA recommendations with combivir being administered as separate component medications in patients with creatinine clearance <50mL/min.
Method comparison
A comparison of the performance of the equations in estimating GFR in the study population showed the 4v-MDRD vs CKD-EPI comparison giving consistently lower bias than the CKD-EPI vs Cockcroft-Gault comparison which also gave a lower bias in relation to the 4v-MDRD vs CockcroftGault comparison. The lower bias observed in the 4v-MDRD vs CKD-EPI should reduce the rate of false-positive diagnoses of stage 3 renal insufficiency (estimated GFR <60 mL/min/1.73m 2 ) in patients without renal insufficiency and no markers of kidney damage. The ability of the CKD-EPI equation to compare well with the 4v-MDRD equation, the recommended equation for staging CKD 11 , simply means that the CKD-EPI equation although not validated in our study population could be used interchangeably with the 4v-MDRD equation for effective staging of renal insufficiency in HIV-infected patients. Cockcroft-Gault equation on the other hand underestimates GFR compared to the 4v-MDRD and CKD-EPI equations and could lead to falsely low GFR's which could lead to insufficient drug dosing in patients without renal insufficiency. This observation is in agreement with our previous finding among CKD patients 20 .
Study predictors
In the linear regression model to assess the ability of creatinine, weight, age, CD4 and albumin to predict GFR in all the estimating equations, creatinine and age showed reciprocal relationship to GFR. Endogenous creatinine is solely excreted by the kidneys and a fractional reduction in urine creatinine excretion will lead to an increase in serum concentrations of creatinine hence reduced GFR being associated with high serum creatinine concentration. Older age is an independent predictor of lower GFR and mainly reflects the relationship between age and muscle mass 22 . Lower muscle mass in older persons causes lower urine creatinine excretion because of the lower serum creatinine concentration hence the negative relationship. Weight and CD4 gave positive linear relationship with GFR estimated with the equations. Increase in body weight is associated with increase in muscle mass with proportional increase in creatinine production which is excreted with a fractional increase in GFR. Cockcroft-Gault equation incorporates creatinine (inverse relationship), weight (direct relationship) and age (natural scale) in estimating GFR whilst CKD-EPI incorporates log serum creatinine (modeled as a 2-slope linear spline with sex specific knots at 0.7mg/dL for women and 0.9mg/dL in men) and age (on a natural scale) 23 and 4v-MDRD incorporates log serum creatinine (without a spline) and age (on log scale) 23 . The composition and variables in the estimating equations may explain some of the differences in their ability to estimate GFR. Weight was an independent predictor of estimated GFR in the Cockcroft-Gault equation than in the 4v-MDRD and CKD-EPI equations and this could be attributed to weight in a direct relationship to GFR in the Cockcroft-Gault equation compared to the latter equations which have been adjusted for body surface area. Serum creatinine is a strong predictor of GFR in the CKD-EPI equation and CD4 which is not included in any of the estimating equations was a strong predictor of GFR in the Cockcroft-Gault equation. The Cockcroft-Gault equation, which is recommended for dose modification, may therefore serve as an invaluable tool in the HIV-infected population if an adjustment could be made for the inclusion of CD4 results. The association of serum creatinine and the CKD-EPI equation may give an added reason why the CKD-EPI equation would be a better tool in staging renal insufficiency in HIVinfected patients 24 . reported a CKD prevalence of about 50% in the elderly population and the significant finding of increases in age and weight in patients on HAART and females on HAART compared to their HAART-naïve counterparts calls for a critical assessment of GFR in this study group for effective dosage adjustment in the presence of renal insufficiency.
Conclusion
Results from this study provides evidence of the presence of renal insufficiency in HIV-infected patients in Ghana, a significant proportion of who will require dose adjustment at the time of initiation of therapy or sometime during ongoing therapy (as realized with patients on HAART in this study). The CKD-EPI equation could serve as the best equation for staging of renal insufficiency in this study population considering its low bias in comparison to the 4v-MDRD equation and its strong association with serum creatinine concentration.
Study limitations
1. The study's inability to estimate creatinine clearance (gold standard) for each of the participating patients was a major limitation which made it virtually impossible to assess how the estimating equations compare to the gold standard. Caution should therefore be exercised in adopting any of the estimating equations in this study cohort. 2. The study is unable to confidently distinguish between patients with acute renal insufficiency from those with chronic kidney disease. 3. Factors such as diet, protein intake and muscle wasting can and may have had profound effect on estimated GFR's. 4. The study did not attempt to determine the causes of renal insufficiency among the participants. 5. The estimating equations do not overcome the limitations of serum creatinine as an endogenous filtration marker and as such all creatinine-based equations should be used with caution in people with abnormally high or low muscle mass.
